Hi,
I work within the world of biobanks/cohorts and clearly clinical annotation is a big area and therefore we have been looking at OMOP and the benefits it brings in this area.
We have noticed though that the representation of samples in OMOP is based heavily on their use to generate data.
Do you think there would be any interest in exploring how the European standard for biobank samples (MIABIS) could be integrated within OMOP?
We have several people from this community interested to engage and wondered the best way to do this?